Inflammasomes and Proteostasis Novel Molecular Mechanisms Associated With Atrial Fibrillation

Area of Science:

• Cardiovascular Research
• Molecular Biology
• Pathogenesis of Arrhythmias

Background:

• Atrial fibrillation (AF) is a common, progressive cardiac arrhythmia linked to major risk factors and severe complications like stroke.
• Current AF treatments are primarily symptomatic, offering limited efficacy in preventing disease progression.
• There is a critical need for treatments targeting the underlying molecular mechanisms of AF.

Purpose of the Study:

• To elucidate the molecular mechanisms of inflammasomes and proteostasis derailment in AF pathogenesis.
• To discuss the role of NLRP3 inflammasome activation and its impact on cardiomyocyte remodeling.
• To highlight pathways of proteostasis disruption, including heat shock proteins, cytoskeletal protein regulation, and NAD+ depletion in AF.

Main Methods:

• Review and synthesis of recent research findings on inflammasomes and proteostasis in AF.
• Detailed discussion of molecular pathways, including NLRP3 inflammasome activation.
• Exploration of proteostasis mechanisms such as heat shock protein function, histone deacetylase activity, and DNA damage response.

Main Results:

• Inflammasomes, particularly NLRP3, play a significant role in AF pathogenesis and cardiomyocyte remodeling.
• Proteostasis pathways, including heat shock protein exhaustion and cytoskeletal disruption, contribute to AF development.
• DNA damage-induced NAD+ depletion is identified as a novel factor underlying AF.

Conclusions:

• Inflammasomes and proteostasis derailment represent key molecular pathways driving AF.
• Understanding these mechanisms reveals potential interactions and identifies novel therapeutic targets for AF.
• Targeting NLRP3 inflammasome and proteostasis pathways offers a promising strategy for mechanistic AF treatment.